Literature DB >> 22724878

Sampling error in histopathology findings of nonalcoholic fatty liver disease: a post mortem liver histology study.

Shahin Merat1, Rasoul Sotoudehmanesh, Mehdi Nouraie, Masoumeh Peikan-Heirati, Sadaf G Sepanlou, Reza Malekzadeh, Masoud Sotoudeh.   

Abstract

BACKGROUND: Many clinical trials and natural history studies on nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) rely heavily on liver histology to define their endpoints. There are many indications that the liver is not uniformly involved in NAFLD thus sampling error is a major concern. This study aims to evaluate the uniformity of various histologic features in livers affected with NAFLD.
METHODS: Samples from a forensic autopsy series were studied and subjects with NAFLD identified.  We took specimens from three different parts of each liver and recorded the degrees of steatosis, hepatocyte ballooning, lobular inflammation, portal inflammation, and fibrosis. A NASH activity index (NAI) which is the sum of scores of histologic features was also calculated. The agreement between the 3 samples from each liver was studied.
RESULTS: There were 945 autopsies performed; 896 were suitable for histologic evaluation and 283 had NAFLD. Of these, 146 livers were available to our study from which 438 samples were taken. Fibrosis[intra-class correlation (ICC) = 0.87], lobular inflammation (kappa = 0.83), and portal inflammation (kappa = 0.83)were fairly uniformly distributed in the damaged liver. Steatosis was less uniform (kappa = 0.64), and hepatocyte ballooning was least uniformly distributed (kappa = 0.57). The ICC for NAI was 0.86, which indicated good agreement.
CONCLUSION: The individual histologic features of NAFLD and NASH are not uniformly distributed in the liver. Hepatocyte ballooning is especially non-uniform. Such non-uniformity should be taken into account when interpreting results of studies that rely on paired biopsies. A summary score such as NAI is less affected by sampling error.

Entities:  

Mesh:

Year:  2012        PMID: 22724878     DOI: 012157/AIM.009

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  9 in total

1.  Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study.

Authors:  Maciej Adler; Licia Larocca; Francesca M Trovato; Heather Marcinkowski; Yasmin Pasha; Simon D Taylor-Robinson
Journal:  HPB (Oxford)       Date:  2016-06-09       Impact factor: 3.647

2.  Evaluation of the histological variability of core and wedge biopsies in nonalcoholic fatty liver disease in bariatric surgical patients.

Authors:  Geraldine J Ooi; Andrew Clouston; Yazmin Johari; William W Kemp; Stuart K Roberts; Wendy A Brown; Paul R Burton
Journal:  Surg Endosc       Date:  2020-03-13       Impact factor: 4.584

3.  Hepatic steatosis and steatohepatitis: Are they really two distinct entities?

Authors:  Cory M Fielding; Paul Angulo
Journal:  Curr Hepatol Rep       Date:  2014-06-01

Review 4.  Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran.

Authors:  I Moghaddasifar; K B Lankarani; M Moosazadeh; M Afshari; A Ghaemi; M Aliramezany; R Afsar Gharebagh; M Malary
Journal:  Int J Organ Transplant Med       Date:  2016-08-01

5.  Decreased liver stiffness by transient elastography indicates lower incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Yinghua Zhang; Chuanfang Wang; Hui Li; Yuanyuan Ding
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

6.  Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH.

Authors:  Mona Hegazy; Shereen A Saleh; Ahmed Ezzat; Mervat E Behiry
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-10       Impact factor: 3.168

7.  Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?

Authors:  Dominika Maciejewska; Arleta Drozd; Karolina Skonieczna-Żydecka; Marta Skórka-Majewicz; Karolina Dec; Karolina Jakubczyk; Anna Pilutin; Ewa Stachowska
Journal:  Molecules       Date:  2020-04-27       Impact factor: 4.411

8.  Comparison of reader agreement, correlation with liver biopsy, and time-burden sampling strategies for liver proton density fat fraction measured using magnetic resonance imaging in patients with obesity: a secondary cross-sectional study.

Authors:  Di Cao; Mengyi Li; Yang Liu; He Jin; Dawei Yang; Hui Xu; Han Lv; JIa Liu; Peng Zhang; Zhongtao Zhang; Zhenghan Yang
Journal:  BMC Med Imaging       Date:  2022-05-17       Impact factor: 1.930

9.  Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague-Dawley rats.

Authors:  Victoria Svop Jensen; Henning Hvid; Jesper Damgaard; Helle Nygaard; Camilla Ingvorsen; Erik Max Wulff; Jens Lykkesfeldt; Christian Fledelius
Journal:  Diabetol Metab Syndr       Date:  2018-01-24       Impact factor: 3.320

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.